GAD1 and depressive symptom measurement: As mentioned, several other studies have found that women are experiencing greater levels of anxiety and depression following the COVID-19 pandemic8–11, which is consistent with non-man participants in our sample intersecting with age to lead to increased post-pandemic levels of GAD-2 and PHQ-9.